Arcadia Biosciences (RKDA) Reports Q2 Loss of $2.02

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($2.02), versus ($1.88) reported last year. Revenue for the quarter came in at $436 thousand versus the consensus estimate of $991 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA maintains underperform ratings on six BDC stocks
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'